{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:25:19Z","timestamp":1784215519717,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11655-023-3609-0","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T15:04:42Z","timestamp":1690815882000},"page":"867-874","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Reyanning Mixture on Asymptomatic or Mild SARS-CoV-2 Infection in Children and Adolescents: A Randomized Controlled Trial"],"prefix":"10.1007","volume":"29","author":[{"given":"Xiang-ru","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-qiang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-ze","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang-jiang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,31]]},"reference":[{"key":"3609_CR1","unstructured":"World Health Organization. WHO coronavirus (COVID-19) dashboard. Accessed February 7, 2023. Available at https:\/\/covid19.who.int\/."},{"key":"3609_CR2","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239\u20131242.","journal-title":"JAMA"},{"key":"3609_CR3","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s12519-022-00570-0","volume":"18","author":"JG Zhou","year":"2022","unstructured":"Zhou JG, Lu YM, Wang LB, Yu H, Zhang T, Chen YW, et al. Pediatric patients in the new wave of SARS-CoV-2 infection in Shanghai, China. World J Pediatr 2022;18:579\u2013581.","journal-title":"World J Pediatr"},{"key":"3609_CR4","unstructured":"American Academy of Pediatrics. Children and COVID-19: state-level data report. Accessed February 7, 2023. Available at https:\/\/www.aap.org\/en\/pages\/2019-novel-coronavirus-covid-19-infections\/children-and-covid-19-state-level-data-report\/."},{"key":"3609_CR5","doi-asserted-by":"publisher","unstructured":"Wang L, Berger NA, Kaelber DC, Davis PB, Volkow ND, Xu R. Comparison of outcomes from COVID infection in pediatric and adult patients before and after the emergence of Omicron. medRxiv 2022. doi: https:\/\/doi.org\/10.1101\/2021.12.30.21268495.","DOI":"10.1101\/2021.12.30.21268495"},{"key":"3609_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12519-020-00343-7","volume":"16","author":"K Shen","year":"2020","unstructured":"Shen K, Yang Y, Wang T, Zhao D, Jiang Y, Jin R, et al. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts\u2019 consensus statement. World J Pediatr 2020;16:223\u2013231.","journal-title":"World J Pediatr"},{"key":"3609_CR7","unstructured":"World Health Organization. WHO expert meeting on evaluation of traditional Chinese medicine in the treatment of COVID-19. Accessed July 31, 2022. Available at https:\/\/www.who.int\/publications\/m\/item\/who-expert-meeting-on-evaluation-of-traditional-chinese-medicine-in-the-treatment-of-covid-19."},{"key":"3609_CR8","first-page":"1476","volume":"47","author":"J Lyu","year":"2022","unstructured":"Lyu J, Wang ZF, Xie YM, Cheng FJ, Zhang Q, Cui X. Clinical comprehensive evaluation of Reyanning Mixture in treatment of acute upper respiratory tract infection (heat-toxin attacking lung syndrome). China J Chin Mater Med (Chin) 2022;47:1476\u20131483.","journal-title":"China J Chin Mater Med (Chin)"},{"key":"3609_CR9","first-page":"3282","volume":"45","author":"J Lyu","year":"2020","unstructured":"Lyu J, Yang C, Wang LX, Xie YM, Yu XQ, Gu L, et al. Randomized double-blind parallel controlled multicenter trial of Reyanning Mixture in treatment of acute tonsillitis. China J Chin Mater Med (Chin) 2020;45:3282\u20133291.","journal-title":"China J Chin Mater Med (Chin)"},{"key":"3609_CR10","first-page":"1465","volume":"45","author":"L Bao","year":"2020","unstructured":"Bao L, Shi YJ, Gen ZH, Sun J, Zhao RH, Du CQ, et al. Application of Reyanning Mixture in evaluating combining disease with syndrome of human coronavirus pneumonia with pestilence attacking lung syndrome. China J Chin Mater Med (Chin) 2020;45:1465\u20131472.","journal-title":"China J Chin Mater Med (Chin)"},{"key":"3609_CR11","first-page":"7","volume":"26","author":"MB Yang","year":"2020","unstructured":"Yang MB, Dang SS, Huang S, Li YJ, Guo YL. Multi-center clinical observation of Reyanning Mixture in treatment of COVID-19. Chin J Exp Tradit Med Form (Chin) 2020;26:7\u201312.","journal-title":"Chin J Exp Tradit Med Form (Chin)"},{"key":"3609_CR12","doi-asserted-by":"publisher","first-page":"154514","DOI":"10.1016\/j.phymed.2022.154514","volume":"108","author":"X Xu","year":"2023","unstructured":"Xu X, Zhou S, Chen C, Li J, Wu H, Jin G, et al. Efficacy and safety of Reyanning Mixture in patients infected with SARS-CoV-2 Omicron variant: a prospective, open-label, randomized controlled trial. Phytomedicine 2023;108:154514.","journal-title":"Phytomedicine"},{"key":"3609_CR13","first-page":"1040","volume":"34","author":"XB Zhou","year":"2020","unstructured":"Zhou XB, Guo J, Cao ZJ, Chu YJ, Huo GT, Qu Z, et al. Toxicological studies of Reyanning Mixture on juvenile animals. Chin Pharm Affairs (Chin) 2020;34:1040\u20131046.","journal-title":"Chin Pharm Affairs (Chin)"},{"key":"3609_CR14","first-page":"141","volume":"36","author":"H Wang","year":"2019","unstructured":"Wang H, Chu YJ, Liu YF, Tian WZ, Liu DX, Zhang SC, et al. Multicenter clinical research to treat the acute upper respiratory tract infection in children with Reyanning Mixture. Tianjin J Tradit Chin Med (Chin) 2019;36:141\u2013144.","journal-title":"Tianjin J Tradit Chin Med (Chin)"},{"key":"3609_CR15","first-page":"29","volume":"41","author":"YJ Su","year":"2021","unstructured":"Su YJ, Liu HN, Du X, Zhang XH, Zhang XJ. HPLC fingerprint of Reyanning Mixture. Modern Tradit Chin Med (Chin) 2021;41:29\u201333.","journal-title":"Modern Tradit Chin Med (Chin)"},{"key":"3609_CR16","first-page":"449","volume":"34","author":"X Xu","year":"2022","unstructured":"Xu X, Sun D, Cao M, Zhang W, Pu Y, Chen C, et al. Analysis of clinical characteristics and prognosis of 4264 patients with asymptomatic and mild novel coronavirus infections in Shanghai. Chin Critic Care Med (Chin) 2022;34:449\u2013453.","journal-title":"Chin Critic Care Med (Chin)"},{"key":"3609_CR17","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1016\/S0140-6736(22)00838-8","volume":"399","author":"X Zhang","year":"2022","unstructured":"Zhang X, Zhang W, Chen S. Shanghai\u2019s life-saving efforts against the current Omicron wave of the COVID-19 pandemic. Lancet 2022;399:2011\u20132012.","journal-title":"Lancet"},{"key":"3609_CR18","doi-asserted-by":"publisher","first-page":"100592","DOI":"10.1016\/j.lanwpc.2022.100592","volume":"29","author":"Z Chen","year":"2022","unstructured":"Chen Z, Deng X, Fang L, Sun K, Wu Y, Che T, et al. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study. Lancet Reg Health West Pac 2022;29:100592.","journal-title":"Lancet Reg Health West Pac"},{"key":"3609_CR19","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/jmv.27491","volume":"94","author":"SJ Gao","year":"2022","unstructured":"Gao SJ, Guo H, Luo G. Omicron variant (B.1.1.529) of SARS-CoV-2, a global urgent public health alert! J Med Virol 2022;94:1255\u20131256.","journal-title":"J Med Virol"},{"key":"3609_CR20","unstructured":"World Health Organization. Enhancing response to Omicron SARS-CoV-2 variant. Accessed July 31, 2022. Available at https:\/\/www.who.int\/publications\/m\/item\/enhancing-readiness-for-omicron-(b.1.1.529)-technical-brief-and-priority-actions-for-member-states."},{"key":"3609_CR21","unstructured":"World Health Organization. Weekly epidemiological update on COVID-19-1 February 2023. Accessed February 8, 2023. Available at https:\/\/www.who.int\/publications\/m\/item\/weekly-epidemiological-update-on-covid-19\u20141-february-2023."},{"key":"3609_CR22","doi-asserted-by":"publisher","first-page":"591132","DOI":"10.3389\/fped.2020.591132","volume":"8","author":"B Li","year":"2020","unstructured":"Li B, Zhang S, Zhang R, Chen X, Wang Y, Zhu C. Epidemiological and clinical characteristics of COVID-19 in children: a systematic review and meta-analysis. Front Pediatr 2020;8:591132.","journal-title":"Front Pediatr"},{"key":"3609_CR23","doi-asserted-by":"crossref","unstructured":"Wang L, Berger NA, Kaelber DC, Davis PB, Volkow ND, Xu R. COVID infection severity in children under 5 years old before and after Omicron emergence in the US. medRxiv 2022.01.12.22269179.","DOI":"10.1101\/2022.01.12.22269179"},{"key":"3609_CR24","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.15585\/mmwr.mm7036e2","volume":"70","author":"MJ Delahoy","year":"2021","unstructured":"Delahoy MJ, Ujamaa D, Whitaker M, O\u2019Halloran A, Anglin O, Burns E, et al. Hospitalizations associated with COVID-19 among children and adolescents-COVID-NET, 14 States, March 1, 2020-August 14, 2021. MMWR Morb Mortal Wkly Rep 2021;70:1255\u20131260.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"3609_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3390\/vaccines10030421","volume":"10","author":"P Gao","year":"2022","unstructured":"Gao P, Cai S, Liu Q, Du M, Liu J, Liu M. Effectiveness and safety of SARS-CoV-2 vaccines among children and adolescents: a systematic review and meta-analysis. Vaccines (Basel) 2022;10:421.","journal-title":"Vaccines (Basel)"},{"key":"3609_CR26","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s40264-021-01131-6","volume":"44","author":"N Luxi","year":"2021","unstructured":"Luxi N, Giovanazzi A, Capuano A, Crisafulli S, Cutroneo PM, Fantini MP, et al. COVID-19 vaccination in pregnancy, paediatrics, immunocompromised patients, and persons with history of allergy or prior SARS-CoV-2 infection: overview of current recommendations and pre- and post-marketing evidence for vaccine efficacy and safety. Drug Saf 2021;44:1247\u20131269.","journal-title":"Drug Saf"},{"key":"3609_CR27","doi-asserted-by":"publisher","first-page":"105252","DOI":"10.1016\/j.antiviral.2022.105252","volume":"198","author":"L Vangeel","year":"2022","unstructured":"Vangeel L, Chiu W, De Jonghe S, Maes P, Slechten B, Raymenants J, et al. Remdesivir, molnupiravir and nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern. Antiviral Res 2022;198:105252.","journal-title":"Antiviral Res"},{"key":"3609_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa2116846","volume":"386","author":"RL Gottlieb","year":"2022","unstructured":"Gottlieb RL, Vaca CE, Paredes R, Mera J, Webb BJ, Perez G, et al. Early remdesivir to prevent progression to severe COVID-19 in outpatients. N Engl J Med 2022;386:305\u2013315.","journal-title":"N Engl J Med"},{"key":"3609_CR29","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa2116044","volume":"386","author":"A Jayk Bernal","year":"2022","unstructured":"Jayk Bernal A, Gomes da Silva MM, Musungaie DB, Kovalchuk E, Gonzalez A, Delos Reyes V, et al. Molnupiravir for oral treatment of COVID-19 in nonhospitalized patients. N Engl J Med 2022;386:509\u2013520.","journal-title":"N Engl J Med"},{"key":"3609_CR30","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","volume":"386","author":"J Hammond","year":"2022","unstructured":"Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19. N Engl J Med 2022;386:1397\u20131408.","journal-title":"N Engl J Med"},{"key":"3609_CR31","unstructured":"FDA. Coronavirus (COVID-19) update: FDA authorizes first oral antiviral for treatment of COVID-19. Accessed July 31, 2022. Available at https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19."},{"key":"3609_CR32","doi-asserted-by":"publisher","first-page":"104425","DOI":"10.1016\/j.jcv.2020.104425","volume":"128","author":"H Peng","year":"2020","unstructured":"Peng H, Gao P, Xu Q, Liu M, Peng J, Wang Y, et al. Coronavirus disease 2019 in children: characteristics, antimicrobial treatment, and outcomes. J Clin Virol 2020;128:104425.","journal-title":"J Clin Virol"},{"key":"3609_CR33","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s11655-022-3673-x","volume":"28","author":"XR Xu","year":"2022","unstructured":"Xu XR, Zhang W, Wu XX, Huang TR, Zuo JG, Shao Z, et al. Effectiveness and safety of Baidu Jieduan Granules for COVID-19: a retrospective observational multicenter study. Chin J Integr Med 2022;28:885\u2013893.","journal-title":"Chin J Integr Med"},{"key":"3609_CR34","doi-asserted-by":"publisher","first-page":"154665","DOI":"10.1016\/j.phymed.2023.154665","volume":"111","author":"X Xu","year":"2023","unstructured":"Xu X, Wu H, Jin G, Huang J, Li J, Zhou J, et al. Efficacy of Lianhua Qingwen for children with SARS-CoV-2 Omicron infection: a propensity score-matched retrospective cohort study. Phytomedicine 2023;111:154665.","journal-title":"Phytomedicine"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-023-3609-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-023-3609-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-023-3609-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T14:34:12Z","timestamp":1696862052000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-023-3609-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,31]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["3609"],"URL":"https:\/\/doi.org\/10.1007\/s11655-023-3609-0","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,31]]},"assertion":[{"value":"5 May 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no financial conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}